Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection

Patients with end stage kidney disease receiving in-center hemodialysis (ICHD) have had high rates of SARS-CoV-2 infection. Following infection, patients receiving ICHD frequently develop circulating antibodies to SARS-CoV-2, even with asymptomatic infection. Here, we investigated the durability and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Kidney Int
Autori principali: Clarke, Candice L., Prendecki, Maria, Dhutia, Amrita, Gan, Jaslyn, Edwards, Claire, Prout, Virginia, Lightstone, Liz, Parker, Eleanor, Marchesin, Federica, Griffith, Megan, Charif, Rawya, Pickard, Graham, Cox, Alison, McClure, Myra, Tedder, Richard, Randell, Paul, Greathead, Louise, Guckian, Mary, McAdoo, Stephen P., Kelleher, Peter, Willicombe, Michelle
Natura: Artigo
Lingua:Inglês
Pubblicazione: International Society of Nephrology. Published by Elsevier Inc. 2021
Soggetti:
Clinical Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992297/
https://ncbi.nlm.nih.gov/pubmed/33774082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2021.03.009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi